U.S. markets closed
  • S&P Futures

    4,120.75
    +13.75 (+0.33%)
     
  • Dow Futures

    34,013.00
    +75.00 (+0.22%)
     
  • Nasdaq Futures

    13,170.25
    +70.00 (+0.53%)
     
  • Russell 2000 Futures

    2,175.20
    +6.60 (+0.30%)
     
  • Crude Oil

    63.51
    -0.31 (-0.49%)
     
  • Gold

    1,822.80
    -1.20 (-0.07%)
     
  • Silver

    27.06
    -0.00 (-0.01%)
     
  • EUR/USD

    1.2086
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.6680
    -0.0270 (-1.59%)
     
  • Vix

    23.13
    -4.46 (-16.17%)
     
  • GBP/USD

    1.4036
    -0.0016 (-0.11%)
     
  • USD/JPY

    109.6080
    +0.1740 (+0.16%)
     
  • BTC-USD

    49,688.48
    -701.73 (-1.39%)
     
  • CMC Crypto 200

    1,361.90
    -26.01 (-1.87%)
     
  • FTSE 100

    6,963.33
    -41.30 (-0.59%)
     
  • Nikkei 225

    27,890.27
    +442.26 (+1.61%)
     

Hologic (HOLX) Partners With Gallup on Women's Health Index

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Hologic, Inc. HOLX recently entered into a multi-year initiative with Gallup, Inc. to develop Hologic Global Women’s Health Index. Notably, Hologic conducted Global Women’s Health Index survey through Gallup’s World Poll in more than 115 countries.

Hologic’s Global Women’s Health Index will generate distinctive insight on reproductive health, domestic violence, preventive care, access to care and early detection of disease.

For investors’ note, Gallup World Poll survey connects with more than 90% of the world's adult population through annual, nationally representative surveys with comparable metrics across countries.

With the recent development, Hologic aims to expand access in women’s healthcare market.

More in the News

Hologic started working with Gallup in 2019 to fortify the grounds of its continuous efforts to support women’s health around the world. The collaboration is helping Hologic bridge the gap of a critical need for a data-driven approach to women’s health.

Hologic in partnership with Gallup highlighted eight essential questions to provide meaningful data on women’s health. Moreover, to ensure complete assessment of women’s health, the index will be featured by country-level reports as well as rankings indicating how countries manage on key indicators of women’s health.

Global Women’s Health Index and Its Progress

As part of a multi-year initiative, Hologic conducted Global Women’s Health survey through Gallup World Poll to track critical aspects of women’s health and safety globally. Notably, the survey included individual responses from more than 120,000 people across 116 countries and in 40 languages.

Per management, the Hologic Global Women’s Health Index will bring awareness to the most vital health issues women are facing globally by offering unique regional insights.

Recent Developments in Women’s Health

Hologic has been making impressive progress in its Breast Health arm over the past few months. The company launched the SuperSonic MACH 20 ultrasound system in January. The same month, Hologic announced the availability of 3D ultrasound imaging on the SuperSonic MACH 30 and 20 ultrasound systems in Europe.

Also in January, Hologic announced plans to acquire Biotheranostics, a privately-held commercial-stage company providing molecular diagnostic tests for breast and metastatic cancer.

Within GYN Surgical, Hologic launched its latest CE-marked Fluent fluid management system in Europe in January 2021. The system is equipped with an integrated MyoSure controller, which can maximize the MyoSure system’s performance with Fluent’s fluid and vacuum systems.

The company, in November 2020, launched the Omni Suite (a comprehensive surgical offering designed to optimize diagnostic and operative hysteroscopy) and acquired Acessa Health (in the field of minimally-invasive treatment for fibroids).

Industry Prospects

Per a report by Grand View Research, the global women’s health market size was worth $32 billion in 2019 and is projected to see a CAGR of 4.9% by 2027. An increase in the population of women aged over 60, a rise in the adoption of unhealthy lifestyle habits and the introduction of novel medicines for women are driving the market.

Price Performance

Shares of the company have gained 61% in a year’s time compared with the industry’s growth of 26.8%.

Zacks Rank and Other Key Picks

Currently, Hologic carries a Zacks Rank #2 (Buy).

A few same-ranked stocks from the broader medical space are ConforMIS, Inc. CFMS, IDEXX Laboratories, Inc. IDXX and Bioanalytical Systems, Inc. BASI. You can see the complete list of Zacks #1 Rank (Strong Buy) stocks here.

ConforMIS has a projected long-term earnings growth rate of 42%.

IDEXX Laboratories has a projected long-term earnings growth rate of 16%.

Bioanalytical Systems has a projected long-term earnings growth rate of 15%.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

IDEXX Laboratories, Inc. (IDXX) : Free Stock Analysis Report

Bioanalytical Systems, Inc. (BASI) : Free Stock Analysis Report

ConforMIS, Inc. (CFMS) : Free Stock Analysis Report

To read this article on Zacks.com click here.